Welcome to LookChem.com Sign In|Join Free

CAS

  • or

3150-24-1

Post Buying Request

3150-24-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • Top Quality 99.0% purity 4-Nitrophenyl-beta-D-galactopyranoside / PNPG / 4-Nitrophenyl-β-D-galactopyranoside 100% Safe Customs Clearance

    Cas No: 3150-24-1

  • USD $ 3.5-3.5 / Gram

  • 10 Gram

  • 600 Kilogram/Month

  • Xi'an Faithful Biotech Co., Ltd.
  • Contact Supplier

3150-24-1 Usage

Description

4-Nitrophenyl-beta-D-galactopyranoside, with the CAS number 3150-24-1, is a chemical compound that features a beta-D-galactopyranoside with a 4-nitrophenyl substituent at the anomeric position. It is a white to light yellow crystalline powder and is primarily used in organic synthesis.

Uses

1. Used in Organic Synthesis:
4-Nitrophenyl-beta-D-galactopyranoside is used as a synthetic intermediate for the production of various organic compounds. Its unique structure allows for specific reactions and modifications, making it a valuable component in the synthesis of complex organic molecules.
2. Used in Enzyme Assays:
In the field of biochemistry and molecular biology, 4-Nitrophenyl-beta-D-galactopyranoside is used as a substrate in enzyme assays, particularly for the detection and quantification of beta-galactosidase activity. 4-Nitrophenyl-beta-D-galactopyranoside serves as a colorimetric indicator, allowing researchers to monitor enzyme activity through the release of the yellow 4-nitrophenol upon enzymatic cleavage.
3. Used in Analytical Chemistry:
4-Nitrophenyl-beta-D-galactopyranoside is also utilized in analytical chemistry for the development of new methods and techniques for the detection and quantification of specific enzymes or other biomolecules. Its distinct chemical properties make it a suitable candidate for the creation of novel analytical protocols.
4. Used in Pharmaceutical Research:
In the pharmaceutical industry, 4-Nitrophenyl-beta-D-galactopyranoside may be employed as a starting material for the development of new drugs targeting enzymes involved in various diseases. Its unique structure can be modified to create potential drug candidates with specific biological activities.
5. Used in Material Science:
4-Nitrophenyl-beta-D-galactopyranoside's properties may also find applications in material science, particularly in the development of new materials with specific interactions or properties. Its ability to form complexes with other molecules could be exploited to create materials with tailored characteristics for various applications.

Purification Methods

Purify the galactoside by recrystallisation from EtOH. [Horikoshi J Biochem (Tokyo) 35 39 1042, Goebel & Avery J Exptl Medicine 50 521 1929, Snyder & Link J Am Chem Soc 7 5 1758.] It is a chromogenic substrate for -galactosidases [Buoncore et al. J Appl Biochem 2 390 1980]. [Beilstein 17/7 V 55.]

Check Digit Verification of cas no

The CAS Registry Mumber 3150-24-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,1,5 and 0 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 3150-24:
(6*3)+(5*1)+(4*5)+(3*0)+(2*2)+(1*4)=51
51 % 10 = 1
So 3150-24-1 is a valid CAS Registry Number.
InChI:InChI=1/C12H15NO8/c14-5-8-9(15)10(16)11(17)12(21-8)20-7-3-1-6(2-4-7)13(18)19/h1-4,8-12,14-17H,5H2/t8?,9-,10+,11?,12+/m0/s1

3150-24-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (N0616)  4-Nitrophenyl β-D-Galactopyranoside [Substrate for β-Galactosidase]  >98.0%(HPLC)

  • 3150-24-1

  • 1g

  • 690.00CNY

  • Detail
  • TCI America

  • (N0616)  4-Nitrophenyl β-D-Galactopyranoside [Substrate for β-Galactosidase]  >98.0%(HPLC)

  • 3150-24-1

  • 5g

  • 2,250.00CNY

  • Detail
  • Alfa Aesar

  • (H56905)  4-Nitrophenyl beta-D-galactopyranoside, 98+%   

  • 3150-24-1

  • 5g

  • 3271.0CNY

  • Detail
  • Alfa Aesar

  • (H56905)  4-Nitrophenyl beta-D-galactopyranoside, 98+%   

  • 3150-24-1

  • 10g

  • 5343.0CNY

  • Detail

3150-24-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-nitrophenyl-β-D-galactoside

1.2 Other means of identification

Product number -
Other names p-Nitrophenyl-Beta-D-Galactopyranoside

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:3150-24-1 SDS

3150-24-1Relevant articles and documents

Direct Synthesis of para-Nitrophenyl Glycosides from Reducing Sugars in Water

Fairbanks, Antony J.,Qiu, Xin

supporting information, (2020/03/24)

Reducing sugars may be directly converted into the corresponding para-nitrophenyl (pNP) glycosides using 2-chloro-1,3-dimethylimidazolinium chloride (DMC), para-nitrophenol, and a suitable base in aqueous solution. The reaction is stereoselective for sugars with either a hydroxyl or an acetamido group at position 2, yielding the 1,2-trans pNP glycosides. A judicious choice of base allows extension to di-and oligosaccharide substrates, including a complex N-glycan oligosaccharide isolated from natural sources, without the requirement of any protecting group manipulations

Development and optimization of a competitive binding assay for the galactophilic low affinity lectin LecA from: Pseudomonas aeruginosa

Joachim, Ines,Rikker, Sebastian,Hauck, Dirk,Ponader, Daniela,Boden, Sophia,Sommer, Roman,Hartmann, Laura,Titz, Alexander

, p. 7933 - 7948 (2016/08/30)

Infections with the Gram-negative bacterium Pseudomonas aeruginosa result in a high mortality among immunocompromised patients and those with cystic fibrosis. The pathogen can switch from planktonic life to biofilms, and thereby shields itself against antibiotic treatment and host immune defense to establish chronic infections. The bacterial protein LecA, a C-type lectin, is a virulence factor and an integral component for biofilm formation. Inhibition of LecA with its carbohydrate ligands results in reduced biofilm mass, a potential Achilles heel for treatment. Here, we report the development and optimization of a fluorescence polarization-based competitive binding assay with LecA for application in screening of potential inhibitors. As a consequence of the low affinity of d-galactose for LecA, the fluorescent ligand was optimized to reduce protein consumption in the assay. The assay was validated using a set of known inhibitors of LecA and IC50 values in good agreement with the known Kd values were obtained. Finally, we employed the optimized assay to screen sets of synthetic thio-galactosides and natural blood group antigens and report their structure-activity relationship. In addition, we evaluated a multivalent fluorescent assay probe for LecA and report its applicability in an inhibition assay.

Glycosynthase with broad substrate specificity-an efficient biocatalyst for the construction of oligosaccharide library

Wei, Jinhua,Lv, Xun,Lue, Yang,Yang, Gangzhu,Fu, Lifeng,Yang, Liu,Wang, Jianjun,Gao, Jianhui,Cheng, Shuihong,Duan, Qian,Jin, Cheng,Li, Xuebing

supporting information, p. 2414 - 2419 (2013/05/23)

A versatile glycosynthase (TnG-E338A) with strikingly broad substrate scope has been developed from Thermus nonproteolyticus β-glycosidase (TnG) by using site-directed mutagenesis. The practical utility of this biocatalyst has been demonstrated by the facile generation of a small library containing various oligosaccharides and a steroidal glycoside (total 25 compounds) in up to 100 % isolated yield. Moreover, an array of eight gluco-oligosaccharides has been readily synthesized by the enzyme in a one-pot, parallel reaction, which highlights its potential in the combinatorial construction of a carbohydrate library that will assist glycomic and glycotherapeutic research. Significantly, the enzyme provides a means by which glycosynthase technology may be extended to combinatorial chemistry.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 3150-24-1